MUHC in the Media - September 30, 2024

Dr. Ronald Postuma, Director of the MUHC Division of neurology and Scientist at the Neuro and the Research Institute of the MUHC, is quoted in an article that presents five possible signs of dementia. The New York Times

Photo : Radio-Canada

Trikafta greatly improves pulmonary health for most patients, but what about psychological health? Dr. Elias Matouk, Director of the Cystic Fibrosis Clinic at the MUHC, reports that, faced with a less dark future than expected, many of his patients may experience psychological distress. Dr. Larry Lands, Director of the Division of Respiratory Medicine at the Montreal Children's Hospital and a scientist at the Research Institute of the MUHC, also comments on the progress associated with this drug. Read the first and second part of this fascinating digital story on radio-canada platform. First part and second part, and listen to Ça nous regarde program, where the reporter Ariane Labrèche is interviewed on Radio-Canada.

Young patients at the Montreal Children's Hospital were able to pet the horses of the Service de police de la Ville de Montréal cavalry and chat with the police officers for a few hours, bringing a little sunshine to their daily lives. The cavalry also circled the Glen site to greet at the window patients who were unable to leave their rooms. TVA Nouvelles, Global News, CityNews, Montreal Gazette

John Kildea, a scientist at the Research Institute of the MUHC, discusses the risks and the benefits for patients of having real-time access to their health data. CBC,  Radio-Canada International

Recently, the publication of preliminary results from a phase 2 clinical trial led by Dr. Kenneth Myers of the Montreal Children's Hospital (MCH) and the Research Institute of the MUHC, and funded by the Liam Foundation, has attracted international attention. These results showed that deoxycytidine/deoxythymidine combination therapy may well be the first safe and potentially effective treatment for POLG disorders, which are rare, devastating neurodegenerative mitochondrial diseases. Since then, The Liam Foundation, named after a MCH patient, has officially partnered with the World Mitochondria Society to increase research into mitochondrial diseases. City News

Over the past 10 years, the use of virtual reality to treat phobias has been gaining in popularity. Several phobias, including the one of flying, can be treated in different virtual environments, with a dozen sessions at the MUHC's Allan Memorial Institute. MUHC psychologist Dr. Jean-Philippe Gagné gave an interview on the subject to host Marie-Ève Tremblay on Radio textos (98,5 FM)

COVID-19 is likely to increase its number of victims over the next few weeks. MUHC microbiologist Dr. Don Vinh reminds us that COVID strikes again and can wreak havoc on a vulnerable population. Once free of charge, tests to detect COVID are now sold in pharmacies, but it can be difficult to find them. CBC Montreal News.

That's the question Dr. Audrey Lafontaine, a pediatrician at the Montreal Children's Hospital, had to answer for the television show Luka et Léo, which aims to answer all the questions asked by children aged 9 to 12. To find out the answer, watch the episode here!

To avoid injuries, schools sometimes tend to tightly regulate children's play in the schoolyard. However, this goes against the recommendations of the Canadian Paediatric Society, which encourages risky play. Solutions do exist, such as creating unstructured play areas, says Liane Fransblow, Trauma Coordinator at the Montreal Children's Hospital. La Presse

Transplant Québec awarded its Grand Prix 2022 to Dr. Sam Shemie, Medical Director of the Pediatric Intensive Care Unit at the Montreal Children's Hospital (MCH) and Associate Investigator at the Research Institute of the McGill University Health Centre (RI-MUHC), in recognition of his outstanding commitment, leadership and professionalism in advancing the practice of organ donation in Quebec, as it is mentioned in its annual report.

Dr. Todd Lee, a scientist at the Research Institute of the MUHC, commented on a new study that found treatment with the antiviral drug remdesivir plus dexamethasone was associated with a reduction in deaths among patients hospitalized with COVID-19. MedPage Today